Balderton Capital, the pan-European venture investor, has announced that Ynon Kreiz has resigned as partner. As a consequence of resigning from Balderton Capital, Kreiz also resigns as a director of a number of the firm’s investee companies.
GP plans to acquire a majority stake in the business, according to a competition authority filing
New GP specialising in healthcare has already deployed 65% of the fund's target
Decision made to halt an initial public offering as a result of volatile market conditions
Sweden-based technology investor has been listed on the Swedish stock exchange since 1997